Trials / Completed
CompletedNCT07367555
Effect Of Sodium Glucose Co-Transporter-2 (SGLT-2) Inhibitors on Body Mass Index After 3 Months of Use in Diabetic Patients
Effect Of Sodium Glucose Co-Transporter-2 (SGLT-2) Inhibitors on Body Mass Index After 3 Months of Use in Diabetic Patients"
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 360 (actual)
- Sponsor
- Ariba Shafiq · Academic / Other
- Sex
- All
- Age
- 30 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Total of 360 participants were enrolled and prescribed oral 200 mg SGLT-2 tablet. All participants were followed-up for about three months. Body mass index was measured before and after three months and mean change in BMI was assessed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Oral 100 gram Empagliflozin tablet along with diet plan and exercise | oral 100 gram Empagliflozin tablet along with diet plan and exercise |
| OTHER | Diet plan and exercise | Only Life style modification was advised. Changes in BMI were assessed. |
Timeline
- Start date
- 2024-10-01
- Primary completion
- 2025-03-31
- Completion
- 2025-03-31
- First posted
- 2026-01-26
- Last updated
- 2026-01-26
Locations
1 site across 1 country: Pakistan
Source: ClinicalTrials.gov record NCT07367555. Inclusion in this directory is not an endorsement.